Elevance Health, Inc. (ELV) short interest & options flow
NYSEElevance Health has printed its Q3 results and the market's pre-earnings defensiveness is visibly unwinding, with the stock up 3.5% on the week to $440.18 and options hedges rolling off. The shift in options positioning is the clearest signal that the earnings anxiety has passed. Before Tuesday's print, the put/call ratio had touched 0.97, the 52-week high. It has since dropped back…
ELV cost to borrow surges 136% in one week to 0.49%, highest since late August, as shares available to short remain ample at 8,515% of short interest.
- Market cap
- $91.96B
- Next earnings
- 27 Jan 2027
Key data as of 8 Nov 2026
ELV news and analysis
RSSNo long-form analysis yet for ELV. Pulse alerts and the live data picture are available on ORTEX.
Open ELV on ORTEX →Want the live picture for ELV?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ELV — free to start on ORTEX.
Sign up for free →Open ELV on ORTEX